What compliance must be adhered to when compounding preparations for animal use?

When compounding preparations for animal use, it is essential to adhere to USP (United States Pharmacopeia) standards, specifically USP 795 for non-sterile compounding and USP 797 for sterile compounding, along with federal law. These guidelines set the standards for safe and effective compounding practices, ensuring quality control and consistency in the preparations made for animals.

Animal compounding, similar to human compounding, must meet stringent requirements to safeguard the health and wellbeing of the animals receiving these medications. Compliance with both USP standards and federal regulations helps assure that the compounding process follows accepted best practices, minimizes the risk of contamination, and guarantees accurate dosing and formulation.

State laws may vary, but they usually align with or mirror federal and USP standards, making them a necessary consideration as well. However, the combined adherence to USP guidelines and federal law is crucial for ensuring that compounded animal medications are safe, effective, and in compliance with recognized standards in the field of veterinary pharmacy. Therefore, the answer highlighting the necessity to comply with USP 795/797 and federal law reflects the comprehensive framework required for the responsible compounding of veterinary preparations.